Literature DB >> 20300400

Antibiotic Sensitivity and Plasmid Profiles of Escherichia coli Isolated from Pediatric Diarrhea.

Babu Uma1, Kesani Prabhakar, Saddayappan Rajendran, Kannaiyan Kavitha, Yelavarthi Lakshmi Sarayu.   

Abstract

BACKGROUND: The emergence of drug resistance among diarrheagenic Escherichia coli (E. coli) in the pediatric population is an important cause of morbidity and mortality in developing countries.
MATERIAL AND METHODS: Isolation and identification of E. coli strains from stool specimens are carried out according to standard techniques. Antibiotic susceptibility testing was performed using disc-diffusion method. Plasmid profiling and conjugation experiments were done to analyze the antibiotic resistance transfer from one bacterium cell to another through plasmid.
RESULTS: Out of 170 pediatric diarrheal samples, 105 (61.76%) E. coli strains were isolated. About 90% of E. coli strains were resistant to most of the antimicrobial agents tested. All the isolates were resistant to ampicillin, imipenem and cotrimoxazole and were sensitive to amikacin. The resistance to antibiotics shows 29 different antibiotic resistance patterns. About 67 (64%) strains of E. coli isolates harbored plasmids, and 51 (76.1%) of them were able to transfer their plasmids. The plasmid sizes ranged from 1.0 to 25 kb, the most common plasmid of size 4.8 kb being detected in all the plasmid-harbored E. coli strains. The results of transconjugation show that all the transconjugant colonies were carrying 4.8-kb plasmid and were resistant to ampicillin, imipenem and cotrimoxazole.
CONCLUSION: There is an increase in the prevalence of drug resistance among E. coli isolates, and conjugal transfer of plasmids has greatly contributed to the rapid spread of antibiotic resistance among E. coli isolates.

Entities:  

Keywords:  Antibiotic sensitivity; Diarrhea; E. coli; Plasmids; Transconjugants

Year:  2009        PMID: 20300400      PMCID: PMC2840953          DOI: 10.4103/0974-777X.56255

Source DB:  PubMed          Journal:  J Glob Infect Dis        ISSN: 0974-777X


INTRODUCTION

Diarrhea is an important cause of morbidity and mortality in the pediatric population of developing countries.[1] In India, diarrheal infections are most commonly caused by Escherichia coli (E. coli), with occasional outbreaks.[2] E. coli strains have been associated with a number of disease syndromes; among these, often severe and fatal infections include pyelonephritis, septicemia, meningitis, endocarditis, urinary tract infections and epidemic diarrhea in adults and children. The major biotypes of E. coli in diarrhea are enterotoxigenic E. coli (ETEC), enteropathogenic E. coli (EPEC), enterohemorrhagic E. coli (EHEC), enteroinvasive E. coli (EIEC), enteroaggregative E. coli (EAEC), and enteroadherent E. coli or diffusely adhering E. coli (DAEC).[3] Fecal, oral and food-borne transmissions of E. coli have been well documented.[4] Bacterial resistance to commonly used antibiotics is a threat to public health throughout the world. Multiple antibiotic resistances in bacteria are most commonly associated with the presence of plasmids which contain one or more resistance genes. Transmission of resistance genes from normally more virulent pathogenic species to nonpathogenic organisms is very common with the animal and human intestinal tract micro flora.[5] Furthermore, the use of antibiotics perpetuated antibiotic resistant plasmids in countries like India, where there is an unrestricted use of antibiotics. In this work, we evaluated the resistance profile of E. coli isolates to commonly used antibiotics and performed plasmid profiles.

MATERIAL AND METHODS

The feces samples were collected from 170 patients below 5 years of age with diarrhea attending the Rajah Muthiah Medical College and Hospital, Annamalainagar, Tamil Nadu, India. Standard procedures were followed for isolation and confirmation of E. coli strains using various biochemical reactions.[6] Serotyping was done at the Central Research Institute, Kasuali, Himachal Pradesh, India.

Antibiotic susceptibility testing

Susceptibility of isolated E. coli strains to different antibiotics was determined by Kirby-Bauer disc-diffusion technique[7] as specified by the National Committee for Clinical Laboratory Standards (NCCLS).[8] The following antibiotics were used: ampicillin (10 μg), amikacin (30 μg), chloramphenicol (30 μg), ciprofloxacin (5 μg), norfloxacin (10 μg), nalidixic acid (30 μg), cotrimoxazole (10 μg), imipenem (10 μg), cefotaxime (30 μg), ceftriaxone (30 μg) and ceftazidime (30 μg). E. coli ATCC 25922 was used as a control.

Conjugation studies

Conjugational transfer was carried out using drug-resistant E. coli as donor and E. coli k12 plasmid-free strain resistant to kanamycin as the recipient, as described by Shohayeb et al.[9] The donors and recipient E. coli cells were grown to logarithmic phase, mixed together in nutrient broth. Conjugation was allowed to take place for 48 hours at 37°C. The mating cells were subcultured into nutrient agar plates containing ampicillin (50 μg/mL) and kanamycin (50 μg/mL) to inhibit the growth of the donor and the recipient. Resistant character was determined by testing all transformants against all antibiotics to which donor strains were resistant. Conjugation was confirmed as positive only when resistant transconjugants were shown to contain a plasmid of a size similar to that found in the original isolate.

Isolation and separation of plasmid DNA

Plasmid DNA was extracted from both donor and transconjugants. Small-scale alkaline lysis method was used as described by Sambrook et al.[10] Extracted plasmids were electrophoresed for 2 hours in a horizontal 0.8% agarose gel with pH 8.0 TBE buffers.[11] The gels were stained with ethidium bromide 0.5 μg/mL for 20 minutes, and bands were visualized by UV transilluminator. Lambda DNA digested with Hind 111 and EcoRI was used as the DNA standard marker.

RESULTS AND DISCUSSION

Out of 170 pediatric diarrheal samples, 105 (61.76%) E. coli strains were isolated. Based on unpublished data, the prevalence of cases of diarrhea in Chidambaram, Tamil Nadu, with a known etiology was 71.83% in summer and 63.1% in monsoon. Diarrhea in children in developing countries has been reported in 50% to 60% of diagnosed cases.[1213] The proportion of diarrheagenic E. coli in Chidambaram was high as compared with that in previous reports from developing countries, as well as from India.[1415] In recent years, it has become clear that E. coli play an important role in the etiology of acute diarrhea.[1617] The major serogroups identified were as follows: 26 strains (24.8%) were O12 serogroup, 21 strains (20%) were O25 serogroup, and 20 (19%) strains were belonged to O60 serogroup. About 10 (9.5%) strains of E. coli were untypable. The resistance to antibiotics shows 29 different antibiotic resistance patterns. Among them, 18 isolates were resistant to ampicillin, imipenem and cotrimoxazole alone. The data presented in Table 1 highlights the emergence of a high rate of drug resistance in E. coli to the common antimicrobial agents used in the treatment of diarrhea. All the isolates were resistant to ampicillin, imipenem and cotrimoxazole and were sensitive to amikacin. The prevalence of drug resistance to ampicillin, chloramphenicol, cotrimoxazole, imipenem, nalidixic acid, norfloxacin was “very high” in our study. This may be due to the indiscriminate use of first-line inexpensive antibiotics in our country. The resistance to ampicillin and imipenem may be due to production of beta-lactamases enzymes, and the most common mechanism for resistance to cotrimoxazole is acquisition of plasmid-encoded, variant diamino-pyrimidine folate reductase enzymes.[18] This may be chromosomal or plasmid mediated. Recently resistances to third-generation cephalosporins have emerged as a major concern, as seen in this study. In India, the emergence of multidrug resistant strains and its variation over the years have been increasing.[14] Appropriate antibiotic therapy for diarrhea reduces mortality and also shortens the duration of symptoms. Increased frequency of drug-resistant E. coli strains is remarkable, since resistance to first-line drugs will require more expensive drugs for effective treatment and may pose a major challenge to the health care system.
Table 1

Antibiotic-resistance patterns of E. coli isolates and plasmid analysis

Antimicrobial resistance patternNo. of isolates (%)No. of strains with plasmids
Ap, I, Co18 (17.14)11
Ap, I, Co, Chl5 (4.76)5
Ap, I, Co, Na2 (1.9)2
Ap, I, Co, Nor9 (8.57)5
Ap, I, Co, Cip5 (4.76)3
Ap, I, Co, Chl, Na2 (1.9)2
Ap, I, Co, Chl, Cip4 (3.81)3
Ap, I, Co, Na, Ca5 (4.76)3
Ap, I, Co, Cip, Nor6 (5.71)1
Ap, I, Co, Cip, Ca8 (7.62)4
Ap, I, Co, Na, Nor1 (0.95)1
Ap, I, Co, Ca, Ci1 (0.95)1
Ap, I, Co, Na, Ci1 (0.95)1
Ap, I, Co, Ca, Ce2 (1.9)1
Ap, I, Co, Chl, Na, Nor2 (1.9)2
Ap, I, Co, Chl, Cip, Ca1 (0.95)-
Ap, I, Co, Chl, Cip, Ce4 (3.81)3
Ap, I, Co, Chl, Nor, Ce2 (1.9)2
Ap, I, Co, Na, Cip, Ce3 (2.86)2
Ap, I, Co, Na, Cip, Ca2 (1.9)1
Ap, I, Co, Na, Ca, Ci3 (2.86)2
Ap, I, Co, Na, Cip, Ci2 (1.9)2
Ap, I, Co, Na, Nor, Ca2 (1.9)2
Ap, I, Co, Na, Nor, Cip2 (1.9)1
Ap, I, Co, Na, Ce, Ca1 (0.95)1
Ap, I, Co, Nor, Cip, Ca3 (2.86)2
Ap, I, Co, Cip, Ca, Ca2 (1.9)-
Ap, I, Co, Cip, Ci, Ce2 (1.9)1
Ap, I, Co, Chl, Na, Cip, Ca, Ci5 (4.76)3

Ap: Ampicillin, I: Imipenem, Co: Cotrimoxazole, Chl: Chloramphenicol, Cip: Ciprofloxacin, Na: Nalidixic acid, Nor: Norfloxacin, Ca: Cefotaxime, Ce: Ceftazidime, Ci: Ceftriaxone

Antibiotic-resistance patterns of E. coli isolates and plasmid analysis Ap: Ampicillin, I: Imipenem, Co: Cotrimoxazole, Chl: Chloramphenicol, Cip: Ciprofloxacin, Na: Nalidixic acid, Nor: Norfloxacin, Ca: Cefotaxime, Ce: Ceftazidime, Ci: Ceftriaxone Approximately 67 (64%) E. coli isolates harbored plasmids, and 51 (76.1%) of them were able to transfer their plasmids. The plasmid size ranged from 1.0 to 25 kb, the most common plasmid of size 4.8 kb being detected in all the plasmid-harbored E. coli strains. Plasmid profile analysis has been widely used in epidemiological investigations.[19] Holmberg et al.[20] reported that plasmid analysis was at least as specific as phage typing. The resistances to antibiotics other than ampicillin, imipenem and cotrimoxazole among E. coli strains were compared with those with and without plasmids, and it was observed that there is high frequency of resistance among E. coli strains with plasmids than without plasmids. There appears to be a constant relationship between a particular plasmid and resistance to antimicrobial agents tested, indicating that there is a potential spread of resistance by conjugation. Conjugative plasmid which mediates multiple resistances was demonstrated by conjugation experiment. The results of transconjugation show that all the transconjugant colonies were resistant to ampicillin, imipenem and cotrimoxazole [Table 2]. All the transconjugants were carrying 4.8 kb plasmid that may be co-transferred either singly or in combination with other plasmids from the parents [Figure 1]. However, conjugation analysis revealed that not all plasmids were transferable by conjugation. Conjugation studies suggest that 4.8-kb plasmid contributes in resistance to ampicillin, imipenem and cotrimoxazole. No attempt was made in this study to determine the homogeneity of 4.8-kb plasmid by compatibility grouping or restriction analysis.
Table 2

Characteristic features of some representative strains of E. coli donors and transconjugants

Bacterial strain no.Resistance patternPlasmid size (Kb)Transconjugants resistance patternPlasmid size (Kb)
E.coli 1Ap. I, Co, Na, Nor25, 4.8, 2.6Ap. I, Co4.8
E.coli 2Ap. I, Co, Nor, Cip, Ca4.8, 1.6, 1.2Ap, I, Co4.8
E.coli 3Ap. I, Co, Na, Cip, Ce4.8, 3.2Ap. I, Co4.8, 3.2
E.coli 4Ap. I, Co, Chl---
E.coli 5Ap. I, Co, Chl, Na4.8, 1.5Ap. I, Co4.8
E.coli 6Ap. I, Co, Na, Nor, Cip,4.8, 2.0, 1.7Ap. I, Co4.8, 1.7
E.coli 7Ap, I, Co, Na, Ca, Ci4.8, 1.5, 1.2--
E.coli 8Ap. I, , Co, Nor, Na4.8, 1.4Ap, I, Co4.8, 1.4
E.coli 9Ap. I, Co, Chl, Na, Cip, Ca, Ci25, 4.8, 2.8Ap, I, Co4.8
E.coli 10Ap, I, Co, Na, Nor, Cip4.8, 1.2Ap, I, co,4.8

Ap: Ampicillin, I: Imipenem, Co: Cotrimoxazole, Chl: Chloramphenicol, Cip: Ciprofloxacin, Na: Nalidixic acid, Nor: Norfloxacin, Ca: Cefotaxime, Ce: ceftazidime, Ci: Ceftriaxone

Figure 1

Plasmid profiles of E.coli isolates and its transconjugants given in lane 1-14, M: Marker Lambda DNA digested with EcoRI and HIND III

Characteristic features of some representative strains of E. coli donors and transconjugants Ap: Ampicillin, I: Imipenem, Co: Cotrimoxazole, Chl: Chloramphenicol, Cip: Ciprofloxacin, Na: Nalidixic acid, Nor: Norfloxacin, Ca: Cefotaxime, Ce: ceftazidime, Ci: Ceftriaxone Plasmid profiles of E.coli isolates and its transconjugants given in lane 1-14, M: Marker Lambda DNA digested with EcoRI and HIND III

CONCLUSION

It has been shown that there is an increase in prevalence of drug resistance among E. coli isolates in our region, and majority of the antibiotic resistances were due to the acquisition of plasmid-carrying antibiotic-resistance genes. Conjugal transfer of plasmids has greatly contributed to the rapid spread of antibiotic resistance among E. coli isolates. Restriction of use of antibiotics may play a role in decreasing the emergence of resistant bacterial strains.
  13 in total

1.  A study of infective aetiology of chronic diarrhoea in children in Amritsar.

Authors:  N Jindal; R Arora; B Bhushan; S Arora
Journal:  J Indian Med Assoc       Date:  1995-05

2.  Antibiotic susceptibility testing by a standardized single disk method.

Authors:  A W Bauer; W M Kirby; J C Sherris; M Turck
Journal:  Am J Clin Pathol       Date:  1966-04       Impact factor: 2.493

Review 3.  Diarrhea in developed and developing countries: magnitude, special settings, and etiologies.

Authors:  R L Guerrant; J M Hughes; N L Lima; J Crane
Journal:  Rev Infect Dis       Date:  1990 Jan-Feb

Review 4.  Diarrheagenic Escherichia coli.

Authors:  J P Nataro; J B Kaper
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

5.  Microbiological agents associated with childhood diarrhoea in the dry zone of Sri Lanka.

Authors:  T E Mertens; R Wijenayake; M R Pinto; J S Peiris; M D Wijesundera; N B Eriyagama; K G Karunarathne; L R Ranaweera
Journal:  Trop Med Parasitol       Date:  1990-03

6.  Patterns of antimicrobial resistance observed in Escherichia coli isolates obtained from domestic- and wild-animal fecal samples, human septage, and surface water.

Authors:  Raida S Sayah; John B Kaneene; Yvette Johnson; RoseAnn Miller
Journal:  Appl Environ Microbiol       Date:  2005-03       Impact factor: 4.792

7.  Antimicrobial resistance in selected bacterial enteropathogens in north India.

Authors:  Neelam Taneja; Balvinder Mohan; Sumeeta Khurana; Meera Sharma
Journal:  Indian J Med Res       Date:  2004-07       Impact factor: 2.375

8.  Comparison of plasmid profile analysis, phage typing, and antimicrobial susceptibility testing in characterizing Salmonella typhimurium isolates from outbreaks.

Authors:  S D Holmberg; I K Wachsmuth; F W Hickman-Brenner; M L Cohen
Journal:  J Clin Microbiol       Date:  1984-02       Impact factor: 5.948

9.  A study of the aetiological agents of childhood diarrhoea in Lagos, Nigeria.

Authors:  T I Ogunsanya; V O Rotimi; A Adenuga
Journal:  J Med Microbiol       Date:  1994-01       Impact factor: 2.472

10.  Studies on transformation of Escherichia coli with plasmids.

Authors:  D Hanahan
Journal:  J Mol Biol       Date:  1983-06-05       Impact factor: 5.469

View more
  11 in total

1.  Investigation of plasmid-mediated resistance in E. coli isolated from healthy and diarrheic sheep and goats.

Authors:  I I Shabana; A T Al-Enazi
Journal:  Saudi J Biol Sci       Date:  2020-01-16       Impact factor: 4.219

Review 2.  Stenotrophomonas maltophilia: an emerging global opportunistic pathogen.

Authors:  Joanna S Brooke
Journal:  Clin Microbiol Rev       Date:  2012-01       Impact factor: 26.132

3.  Prevalence of Antibiotic Resistance in Escherichia coli Fecal Isolates From Healthy Persons and Patients With Diarrhea.

Authors:  Seung-Hak Cho; Yeong-Sik Lim; Mi-Sun Park; Seong-Han Kim; Yeon-Ho Kang
Journal:  Osong Public Health Res Perspect       Date:  2011-05-07

4.  Comparison of phenotypic characteristics and antimicrobial resistance patterns of clinical Escherichia coli collected from two unrelated geographical areas.

Authors:  Mutasim E Ibrahim; Naser E Bilal; Mohamed E Hamid
Journal:  Glob J Health Sci       Date:  2014-07-15

5.  Prevalence of Multidrug-Resistant Escherichia coli Isolated from Drinking Water Sources.

Authors:  Stephen T Odonkor; Kennedy K Addo
Journal:  Int J Microbiol       Date:  2018-08-19

Review 6.  Bird feathers as potential sources of pathogenic microorganisms: a new look at old diseases.

Authors:  Andrzej Miskiewicz; Paweł Kowalczyk; Sanaa Mahdi Oraibi; Krystyna Cybulska; Anna Misiewicz
Journal:  Antonie Van Leeuwenhoek       Date:  2018-02-19       Impact factor: 2.271

Review 7.  Review of Escherichia coli O157:H7 Prevalence, Pathogenicity, Heavy Metal and Antimicrobial Resistance, African Perspective.

Authors:  Sydney M Gambushe; Oliver T Zishiri; Mohamed E El Zowalaty
Journal:  Infect Drug Resist       Date:  2022-08-23       Impact factor: 4.177

8.  Cotrimoxazole prophylaxis was associated with enteric commensal bacterial resistance among HIV-exposed infants in a randomized controlled trial, Botswana.

Authors:  Kathleen M Powis; Sajini Souda; Shahin Lockman; Gbolahan Ajibola; Kara Bennett; Jean Leidner; Michael D Hughes; Sikhulile Moyo; Erik van Widenfelt; Haruna B Jibril; Joseph Makhema; Max Essex; Roger L Shapiro
Journal:  J Int AIDS Soc       Date:  2017-11       Impact factor: 5.396

9.  A study of virulence and antimicrobial resistance pattern in diarrhoeagenic Escherichia coli isolated from diarrhoeal stool specimens from children and adults in a tertiary hospital, Puducherry, India.

Authors:  Mailan Natarajan; Deepika Kumar; Jharna Mandal; Niranjan Biswal; Selvaraj Stephen
Journal:  J Health Popul Nutr       Date:  2018-07-13       Impact factor: 2.000

10.  Genetic relatedness of the Escherichia coli fecal population and strains causing urinary tract infection in the same host.

Authors:  Maryam Bahadori; Mohammad Motamedifar; Abdollah Derakhshandeh; Roya Firouzi; Azar Motamedi Boroojeni; Mohsen Alinejad; Zahra Naziri
Journal:  Microbiologyopen       Date:  2018-10-25       Impact factor: 3.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.